Clinical Trial

Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy

Study acronym: IMPRINT
Recruiting
View on ClinicalTrials.gov →
Summary
To prospectively investigate and integrate radiomic and immunologic signatures in patients with nasopharyngeal carcinoma (NPC) treated with either proton or photon radiotherapy, with the aim of identifying biomarkers associated with treatment response, toxicity, and long-term outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-14.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT07232680
Lead Sponsor Cheng-En Hsieh
Conditions NPC Patients, Nasopharyngeal Cancinoma (NPC)
Enrollment 500 participants
Start Date 2025-11-20
Primary Completion 2031-08-15 (estimated)
Study Completion 2034-08-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-24